(in the BioPark, founded in 2009, 12 employees) designs and develops novel effective antibacterials to combat bacterial pathogens e.g. proteins that are designed by LISANDO in order to efficiently destroy bacteria, using an enzymatic mechanism.
(in the BioPark, founded in 2002, 20 employees) focuses on the development and marketing of innovative immune diagnostic systems to improve therapy control and personalized treatment of patients in the area of transplantation, infectious and autoimmune diseases. The company’s developments are based on its expertise in cell-mediated immunity as well as on its proprietary T-activation® and Reverse T Cell Technology platforms.
(founded in 2001, 2 employees) develops novel pharmaceuticals for diseases like Parkinson's, Alzheimer's, schizophrenia and depression by using innovative neuronal targets (disease-related genes or proteins).
(in the BioPark, founded in 2004, 48 employees) develops and markets integrated test systems for human diagnostics. The fully automated numares systems provide information about formation, extent and severity of diseases in high throughput operations. They ensure improved treatment options at high patient safety and cost-effectiveness.
(in the BioPark, founded in 2009, 6 employees) is a science-based company tackling Androgenetic Alopecia (AGA), which is commonly known as male and female pattern baldness. The company is developing novel effective health and beauty therapies to help people stay young and healthy longer and to extend their quality of life.
(founded in 1988, 46 employees) partner in the field of cell-culture, especially for serum-free systems, cell culture media, custom-made products and research. Application-oriented product optimisation.
(founded in 2016, Subsidiary of PAN Biotech GmbH) develops, produces and markets biotechnological products all around the cell culture.
(founded in 2007, 6 employees) provides quantification of proteins, targeting drug discovery and biomarker validation. Main advantages of the technology are rapid assay development and a high accuracy.
(in the BioPark, founded in 1997, 84 employees) developer and manufacturer of chemical optical sensors and systems for customers in Biotechnology, Pharmacy, Medical Devices, Food Industry and in many other scientific fields.
(founded in 2016, 13 employees) Service provider in the field of development and optimisation of ready-for-the-market products e.g. bone cement based on Nano silver for inflectional prophylaxis. Legal sucessor of rent a scientist GmbH (founded in 1995) and ras materials GmbH (founded in 2010).
(founded in 1995, 260 employees) technology and market leader of the German biogas industry. Planning, construction and operation of ready-to-use peripheral biogas plants. Part of the Viessmann Group since 2010
(founded in 1927, 70 employees) develops and manufactures innovative collagen products for medical and pharmaceutical use (implants and tissue engineering).
(at BioPark, founded in 1999, 250 employees) service provider for gene synthesis and downstream processes (DNA engineering and processing). Provides Synthetic Biology for customers of Pharma- and Biotech-industry. Since 2014 GeneArt belongs to the US-based Thermo Fisher Scientific Inc.